Related Experiment Video
Updated: Jun 8, 2026
06:24
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Recent methodological advances in male hormonal contraception.
Peter Y Liu1, Ronald S Swerdloff, Christina Wang
1Division of Endocrinology, Department of Medicine, General Clinical Research Center, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute (LA BioMed) at Harbor-UCLA Medical Center, Torrance, CA 90509, USA.
Contraception
|October 12, 2010
Summary
Male hormonal contraception (MHC) is effective and reversible, with established short-term safety. Recent integrated analyses predict spermatogenesis suppression and recovery, guiding future large-scale efficacy studies for market readiness.
Area of Science:
- Reproductive endocrinology
- Male reproductive health
- Contraception development
Background:
- Male hormonal contraception (MHC) has demonstrated efficacy for decades.
- Recent advancements confirm MHC reversibility and short-term safety.
- Methodological improvements enhance trial data reliability and interpretation.
Purpose of the Study:
- To analyze factors predicting spermatogenesis suppression and recovery in men using MHC.
- To provide data guiding future Phase III efficacy studies for MHC market approval.
- To offer reassurance for the development of male-directed contraceptive options.
Main Methods:
- Integrated analysis of data from MHC clinical trials over the past 15 years.
- Centralized semen analysis and fluorescence for precise sperm concentration measurement.
- Gas chromatography/mass spectrometry for blood steroid concentration analysis.
- Inclusion of placebo groups to assess androgen and progestin side effects.
Main Results:
- Identification of key factors influencing spermatogenesis suppression and recovery.
- Establishment of sperm quality reference ranges in fertile men.
- Demonstration of MHC's predictable impact on sperm production and its reversal.
Conclusions:
- Integrated analyses provide robust data for predicting MHC outcomes.
- Findings support the progression of specific MHC regimens to large-scale Phase III trials.
- This research is crucial for the successful introduction of male hormonal contraception.
Related Concept Videos
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:23Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:40Hormonal Regulation
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.